Somatropin stocks hit on two fronts

Norditropin Flexpro Image; Novo Nordisk
One version of the synthetic growth hormone in short supply while another is discontinued The somatropin products marketed as Norditropin FlexPro 5mg, 10mg and 15mg will be in shortage until the end of 2023, sponsor Novo Nordisk has told the Therapeutic Goods Administration (TGA). Parallel to that pharmaceutical company Ipsen has notified the TGA it

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Forgot Password?Why do I need to login & stay in?

Previous ‘This is the hill I’m willing to die on.’
Next Government defeats 60-day disallowance motion